• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质背景信息的整合改善了基于蛋白质的新冠肺炎患者分层。

Integration of protein context improves protein-based COVID-19 patient stratification.

作者信息

Gao Jinlong, He Jiale, Zhang Fangfei, Xiao Qi, Cai Xue, Yi Xiao, Zheng Siqi, Zhang Ying, Wang Donglian, Zhu Guangjun, Wang Jing, Shen Bo, Ralser Markus, Guo Tiannan, Zhu Yi

机构信息

Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China.

Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.

出版信息

Clin Proteomics. 2022 Aug 11;19(1):31. doi: 10.1186/s12014-022-09370-0.

DOI:10.1186/s12014-022-09370-0
PMID:35953823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9366758/
Abstract

BACKGROUND

Classification of disease severity is crucial for the management of COVID-19. Several studies have shown that individual proteins can be used to classify the severity of COVID-19. Here, we aimed to investigate whether integrating four types of protein context data, namely, protein complexes, stoichiometric ratios, pathways and network degrees will improve the severity classification of COVID-19.

METHODS

We performed machine learning based on three previously published datasets. The first was a SWATH (sequential window acquisition of all theoretical fragment ion spectra) MS (mass spectrometry) based proteomic dataset. The second was a TMTpro 16plex labeled shotgun proteomics dataset. The third was a SWATH dataset of an independent patient cohort.

RESULTS

Besides twelve proteins, machine learning also prioritized two complexes, one stoichiometric ratio, five pathways, and five network degrees, resulting a 25-feature panel. As a result, a model based on the 25 features led to effective classification of severe cases with an AUC of 0.965, outperforming the models with proteins only. Complement component C9, transthyretin (TTR) and TTR-RBP (transthyretin-retinol binding protein) complex, the stoichiometric ratio of SAA2 (serum amyloid A proteins 2)/YLPM1 (YLP Motif Containing 1), and the network degree of SIRT7 (Sirtuin 7) and A2M (alpha-2-macroglobulin) were highlighted as potential markers by this classifier. This classifier was further validated with a TMT-based proteomic data set from the same cohort (test dataset 1) and an independent SWATH-based proteomic data set from Germany (test dataset 2), reaching an AUC of 0.900 and 0.908, respectively. Machine learning models integrating protein context information achieved higher AUCs than models with only one feature type.

CONCLUSION

Our results show that the integration of protein context including protein complexes, stoichiometric ratios, pathways, network degrees, and proteins improves phenotype prediction.

摘要

背景

疾病严重程度分类对于新冠病毒病(COVID-19)的管理至关重要。多项研究表明,单个蛋白质可用于对COVID-19的严重程度进行分类。在此,我们旨在研究整合四种类型的蛋白质背景数据,即蛋白质复合物、化学计量比、信号通路和网络度,是否会改善COVID-19的严重程度分类。

方法

我们基于三个先前发表的数据集进行机器学习。第一个是基于SWATH(所有理论碎片离子光谱的顺序窗口采集)质谱(MS)的蛋白质组学数据集。第二个是TMTpro 16plex标记的鸟枪法蛋白质组学数据集。第三个是一个独立患者队列的SWATH数据集。

结果

除了12种蛋白质外,机器学习还对两种复合物、一种化学计量比、五条信号通路和五个网络度进行了优先级排序,从而形成了一个包含25个特征的组合。结果,基于这25个特征的模型能够有效分类重症病例,曲线下面积(AUC)为0.965,优于仅使用蛋白质的模型。补体成分C9、转甲状腺素蛋白(TTR)和TTR-RBP(转甲状腺素蛋白-视黄醇结合蛋白)复合物、血清淀粉样蛋白A2(SAA2)/含YLP基序1(YLPM1)的化学计量比,以及沉默调节蛋白7(SIRT7)和α-2-巨球蛋白(A2M)的网络度被该分类器突出显示为潜在标志物。该分类器在来自同一队列的基于TMT的蛋白质组学数据集(测试数据集1)和来自德国的独立的基于SWATH的蛋白质组学数据集(测试数据集2)中得到进一步验证,AUC分别达到0.900和0.908。整合蛋白质背景信息的机器学习模型比仅使用一种特征类型的模型具有更高的AUC。

结论

我们的结果表明,整合包括蛋白质复合物、化学计量比、信号通路、网络度和蛋白质在内的蛋白质背景信息可改善表型预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c394/9367071/c1960d4b2f41/12014_2022_9370_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c394/9367071/c1960d4b2f41/12014_2022_9370_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c394/9367071/c1960d4b2f41/12014_2022_9370_Fig2_HTML.jpg

相似文献

1
Integration of protein context improves protein-based COVID-19 patient stratification.蛋白质背景信息的整合改善了基于蛋白质的新冠肺炎患者分层。
Clin Proteomics. 2022 Aug 11;19(1):31. doi: 10.1186/s12014-022-09370-0.
2
Optimization of Acquisition and Data-Processing Parameters for Improved Proteomic Quantification by Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectrometry.通过全理论碎片离子质谱的顺序窗口采集优化采集和数据处理参数以改进蛋白质组定量分析
J Proteome Res. 2017 Feb 3;16(2):738-747. doi: 10.1021/acs.jproteome.6b00767. Epub 2017 Jan 3.
3
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models.信息论特征选择和机器学习方法在遗传风险预测模型开发中的应用。
Sci Rep. 2021 Dec 2;11(1):23335. doi: 10.1038/s41598-021-00854-x.
4
Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS.应用 SWATH-MS 鉴定与食管癌化疗治疗结果相关的血浆蛋白。
J Proteomics. 2022 Aug 30;266:104684. doi: 10.1016/j.jprot.2022.104684. Epub 2022 Jul 14.
5
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.机器学习对血浆蛋白质组学进行分类,可用于诊断间质性肺病。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):444-454. doi: 10.1164/rccm.202309-1692OC.
6
COVIDpro: Database for mining protein dysregulation in patients with COVID-19.COVIDpro:用于挖掘新冠肺炎患者蛋白质失调情况的数据库。
bioRxiv. 2022 Sep 30:2022.09.27.509819. doi: 10.1101/2022.09.27.509819.
7
SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.SWATH 质谱分析作为基质组定量分析的工具。
J Proteomics. 2018 Oct 30;189:11-22. doi: 10.1016/j.jprot.2018.02.026. Epub 2018 Mar 1.
8
Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.将机器学习中的手工特征与潜在变量相结合,以预测放射性肺损伤。
Med Phys. 2019 May;46(5):2497-2511. doi: 10.1002/mp.13497. Epub 2019 Apr 8.
9
A new hybrid ensemble machine-learning model for severity risk assessment and post-COVID prediction system.一种新的混合集成机器学习模型,用于严重程度风险评估和 COVID 后预测系统。
Math Biosci Eng. 2022 Apr 13;19(6):6102-6123. doi: 10.3934/mbe.2022285.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Research Trends in Proteomic Studies Using Serum from COVID-19 Patients: A Bibliometric Analysis.使用新冠肺炎患者血清的蛋白质组学研究趋势:文献计量分析
Curr Med Chem. 2025;32(12):2275-2290. doi: 10.2174/0109298673286915240329063441.
2
A pathway activity-based proteomic classifier stratifies prostate tumors into two subtypes.一种基于通路活性的蛋白质组学分类器将前列腺肿瘤分为两种亚型。
Clin Proteomics. 2023 Nov 11;20(1):50. doi: 10.1186/s12014-023-09441-w.
3
Immunology of SARS-CoV-2 infection and vaccination.SARS-CoV-2 感染和疫苗接种的免疫学。

本文引用的文献

1
A proteomic survival predictor for COVID-19 patients in intensive care.一种用于重症监护病房中新冠患者的蛋白质组学生存预测指标。
PLOS Digit Health. 2022 Jan 18;1(1):e0000007. doi: 10.1371/journal.pdig.0000007. eCollection 2022 Jan.
2
Complement activation induces excessive T cell cytotoxicity in severe COVID-19.补体激活可导致重症 COVID-19 中 T 细胞过度细胞毒性。
Cell. 2022 Feb 3;185(3):493-512.e25. doi: 10.1016/j.cell.2021.12.040. Epub 2021 Dec 28.
3
Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms.
Clin Chim Acta. 2023 May 1;545:117390. doi: 10.1016/j.cca.2023.117390. Epub 2023 May 13.
下一代血浆蛋白质组学在 COVID-19 轻症和普通型患者中的应用。
EBioMedicine. 2021 Dec;74:103723. doi: 10.1016/j.ebiom.2021.103723. Epub 2021 Nov 27.
4
Potential Use of Serum Proteomics for Monitoring COVID-19 Progression to Complement RT-PCR Detection.血清蛋白质组学在监测 COVID-19 进展以补充 RT-PCR 检测中的潜在应用。
J Proteome Res. 2022 Jan 7;21(1):90-100. doi: 10.1021/acs.jproteome.1c00525. Epub 2021 Nov 16.
5
High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.高分辨率血清蛋白质组轨迹在 COVID-19 中揭示了患者特异性的血清转化。
EMBO Mol Med. 2021 Aug 9;13(8):e14167. doi: 10.15252/emmm.202114167. Epub 2021 Jul 7.
6
A serum proteome signature to predict mortality in severe COVID-19 patients.严重 COVID-19 患者死亡预测的血清蛋白质组特征。
Life Sci Alliance. 2021 Jul 5;4(9). doi: 10.26508/lsa.202101099. Print 2021 Sep.
7
Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.联合代谢激活剂可加速轻度至中度 COVID-19 的康复。
Adv Sci (Weinh). 2021 Sep;8(17):e2101222. doi: 10.1002/advs.202101222. Epub 2021 Jun 28.
8
Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.急性 COVID-19 感染中免疫血清标志物的时间变化的无偏分析,重点关注器官衰竭、抗病毒治疗和人口统计学特征。
Front Immunol. 2021 Jun 11;12:650465. doi: 10.3389/fimmu.2021.650465. eCollection 2021.
9
A time-resolved proteomic and prognostic map of COVID-19.COVID-19 的时分辨证蛋白质组学和预后图谱。
Cell Syst. 2021 Aug 18;12(8):780-794.e7. doi: 10.1016/j.cels.2021.05.005. Epub 2021 Jun 14.
10
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.SARS-CoV-2 RNAemia 和蛋白质组轨迹为入住重症监护病房的 COVID-19 患者的预后提供信息。
Nat Commun. 2021 Jun 7;12(1):3406. doi: 10.1038/s41467-021-23494-1.